|
Tanaka, Motoyoshi; Rosser, Charles J; Grossman, H Barton (2005) PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer. Cancer Detect Prev 29:170-4
|
|
Rosser, Charles J; Tanaka, Motoyoshi; Pisters, Louis L et al. (2004) Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation. Cancer Gene Ther 11:273-9
|
|
Tanaka, Motoyoshi; Grossman, H Barton (2004) Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol Rep 11:537-41
|
|
Lance, Raymond S; Grossman, H Barton (2003) Recent developments in the treatment of bladder cancer. Adv Exp Med Biol 539:3-14
|
|
Gee, Jason; Tanaka, Motoyoshi; Grossman, H Barton (2003) Connexin 26 is abnormally expressed in bladder cancer. J Urol 169:1135-7
|
|
Zou, Changping; Guan, Yongli; Zou, Changchun et al. (2002) N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines. Cancer Lett 180:131-7
|
|
Izawa, J I; Slaton, J W; Kedar, D et al. (2001) Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep 8:9-15
|
|
Albert, P S; McShane, L M; Shih, J H et al. (2001) Latent class modeling approaches for assessing diagnostic error without a gold standard: with applications to p53 immunohistochemical assays in bladder tumors. Biometrics 57:610-9
|
|
Tanaka, M; Grossman, H B (2001) Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with Cisplatin. Hum Gene Ther 12:2225-36
|
|
Grossman, H B; Lee, C; Bromberg, J et al. (2000) Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer. Oncol Rep 7:13-6
|
Showing the most recent 10 out of 31 publications
